RemeGen Co., Ltd. (HKG: 9995)
Hong Kong
· Delayed Price · Currency is HKD 13.48
-0.92 (-6.39%)
Jan 2, 2025, 4:08 PM HKT
RemeGen Market Cap
RemeGen has a market cap or net worth of 12.97 billion as of January 3, 2025. Its market cap has decreased by -61.87% in one year.
Market Cap
12.97B
Enterprise Value
14.75B
Revenue
1.69B
Ranking
n/a
PE Ratio
n/a
Stock Price
13.48
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has decreased from 33.39B to 12.97B, a decrease of -61.15%. That is a compound annual growth rate of -20.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 3, 2025 | 12.97B | -7.38% |
| Dec 31, 2024 | 14.00B | -55.02% |
| Dec 29, 2023 | 31.13B | -25.43% |
| Dec 30, 2022 | 41.75B | 9.42% |
| Dec 31, 2021 | 38.16B | -18.00% |
| Dec 31, 2020 | 46.53B | 39.37% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 152.35B |
| Hansoh Pharmaceutical Group Company | 98.98B |
| JD Health International | 84.44B |
| WuXi Biologics | 68.21B |
| Sinopharm Group | 65.07B |
| Innovent Biologics | 58.15B |
| Sino Biopharmaceutical | 56.25B |
| CSPC Pharmaceutical Group | 53.70B |